TLR9 rs352139 Genetic Variant Promotes Tacrolimus Elimination in Chinese Liver Transplant Patients During the Early Posttransplantation Period.

Abstract:

BACKGROUND:There are limited markers that could facilitate individualized tacrolimus treatment in the early posttransplantation period. Genetic factors have been found to play critical roles in determining tacrolimus pharmacokinetics. OBJECTIVE:We aimed to examine the association of donor and recipient Toll-like receptor (TLR) polymorphisms with tacrolimus elimination and the potential mechanism for TLR gene polymorphism-mediated tacrolimus metabolism. METHODS:Two independent cohorts including 297 patients receiving liver transplantation (LT) were enrolled in this study (cohort A was composed of 200 patients; cohort B included 97 patients and served as a validation set). Toll-like receptors polymorphisms were genotyped using TaqMan single nucleotide polymorphisms (SNPs) assays. The protein expressions were detected by Western blotting. The metabolism assay was used to quantify tacrolimus elimination. The activity of nuclear factor-kB (NF-kB) was evaluated by luciferase reporter assay. RESULTS:Tacrolimus dose-adjusted trough blood concentrations (C/D) ratios were significantly lower for donor TLR9 rs352139 AG/GG carriers than AA carriers at weeks 1, 2, and 3 after LT. In multivariate analysis, donor and recipient CYP3A5 rs776746 and donor TLR9 rs352139 were independent predictors of tacrolimus C/D ratios in the early period after transplantation in both cohorts. When investigating the combined effects of donor CYP3A5 rs776746 and donor TLR9 rs352139 genotypes, the C/D ratios were remarkably significant at all time points during the first month after LT within the four groups. Furthermore, CYP3A5 mRNA expression in liver tissue was significantly higher for AG/GG patients than AA carriers after LT. In addition, we demonstrated that the TLR9 rs352139 genetic variant promotes tacrolimus metabolism of liver cells via upregulation of CYP3A5, which is dependent on the repression of NF-κB/pregnane X receptor (PXR) signaling. CONCLUSIONS:Donor TLR9 rs352139 genetic variant facilitated tacrolimus elimination during the early stage after LT in Chinese patients, which might be related to the upregulation of CYP3A5 enzyme via the NF-kB/PXR signaling pathway.

journal_name

Pharmacotherapy

journal_title

Pharmacotherapy

authors

Ou B,Liu Y,Zhang T,Sun Y,Chen J,Peng Z

doi

10.1002/phar.2204

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

67-76

issue

1

eissn

0277-0008

issn

1875-9114

journal_volume

39

pub_type

杂志文章
  • Extracorporeal Elimination of Piperacillin/Tazobactam during Molecular Adsorbent Recirculating System Therapy.

    abstract::Use of the Molecular Adsorbent Recirculating System (MARS) as a liver support device continues to grow worldwide. Various components of the MARS circuit remove both protein-bound and water-soluble molecules. Little is known about the extent of the enhanced clearance mechanisms used in MARS therapy on drug elimination....

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1618

    authors: Personett HA,Larson SL,Frazee EN,Nyberg SL,El-Zoghby ZM

    更新日期:2015-08-01 00:00:00

  • Concurrent administration of sirolimus and voriconazole: a pilot study assessing safety and approaches to appropriate management.

    abstract:STUDY OBJECTIVES:To assess the use and safety of concurrent administration of voriconazole and sirolimus-which is contraindicated-and to determine approaches for appropriately managing patients who receive both drugs. DESIGN:Retrospective medical record review. SETTING:University-affiliated medical center. PATIENTS:...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.6.719

    authors: Surowiec D,DePestel DD,Carver PL

    更新日期:2008-06-01 00:00:00

  • Acute promyelocytic leukemia after iodine-131 therapy for Graves' disease.

    abstract::Graves' disease is an autoimmune process in which the thyroid gland is stimulated by autoantibodies, leading to hyperthyroidism. Graves' disease is the most common cause of hyperthyroid function, primarily affecting women in their 40s and 50s. Treatment may involve oral radioiodine, which is taken up by the follicular...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.2005.25.7.1017

    authors: Kolade VO,Bosinski TJ,Ruffy EL

    更新日期:2005-07-01 00:00:00

  • Pharmacotherapy of behavioral and psychological symptoms of dementia: time for a different paradigm?

    abstract::Behavioral and psychological symptoms of dementia can occur in 60-80% of patients with Alzheimer's disease or other dementing illnesses, and are important in that they are a source of significant caregiver stress and often precipitate nursing home placement. These symptoms, namely, aggression, delusions, hallucination...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.21.1.74.34437

    authors: Rojas-Fernandez CH,Lanctot KL,Allen DD,MacKnight C

    更新日期:2001-01-01 00:00:00

  • Medication Management of Patients Undergoing Transcatheter Aortic Valve Replacement.

    abstract::Aortic stenosis (AS) is the most common form of valvular heart disease. A detailed diagnostic workup is necessary to promptly stage and classify disease severity to determine optimal management. Medical therapy and valvuloplasty are options that fail to delay or reverse disease progression. Surgical aortic valve repla...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2056

    authors: Kalich BA,Allender JE,Hollis IB

    更新日期:2018-01-01 00:00:00

  • Impact of Stewardship Interventions on Antiretroviral Medication Errors in an Urban Medical Center: A 3-Year, Multiphase Study.

    abstract:BACKGROUND:There is a high prevalence of HIV infection in Newark, New Jersey, with University Hospital admitting approximately 600 HIV-infected patients per year. Medication errors involving antiretroviral therapy (ART) could significantly affect treatment outcomes. The goal of this study was to evaluate the effectiven...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1716

    authors: Zucker J,Mittal J,Jen SP,Cheng L,Cennimo D

    更新日期:2016-03-01 00:00:00

  • Barriers to patient self-testing of prothrombin time: national survey of anticoagulation practitioners.

    abstract::Oral anticoagulation with warfarin requires routine monitoring of prothrombin time, expressed as the international normalized ratio (INR). Patient self-testing for INR is common in Europe but not in the United States. In order to determine the frequency of INR self-testing among patients whose anticoagulant therapy is...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.25.2.265.56949

    authors: Wittkowsky AK,Sekreta CM,Nutescu EA,Ansell J

    更新日期:2005-02-01 00:00:00

  • Neurotoxicity associated with ceftazidime therapy in geriatric patients with renal dysfunction.

    abstract::Ceftazidime, a beta-lactamase-stable, third-generation cephalosporin, is widely used for the treatment of serious gram-negative infections. Neurotoxicity has rarely been associated with the drug; however, two of our patients developed ceftazidime-induced neurotoxicity that produced confusion, disorientation, agitation...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Slaker RA,Danielson B

    更新日期:1991-01-01 00:00:00

  • Aerosolized ceftazidime for prevention of ventilator-associated pneumonia and drug effects on the proinflammatory response in critically ill trauma patients.

    abstract:STUDY OBJECTIVES:To evaluate the safety and efficacy of aerosolized ceftazidime for prevention of ventilator-associated pneumonia (VAP) and to evaluate the effects of the drug on the proinflammatory response. DESIGN:Prospective, randomized, double-blind, placebo-controlled clinical trial. SETTING:University teaching ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.22.12.972.33596

    authors: Wood GC,Boucher BA,Croce MA,Hanes SD,Herring VL,Fabian TC

    更新日期:2002-08-01 00:00:00

  • Prospective validation of an optimal sparse plasma-sampling strategy for estimating ciprofloxacin pharmacokinetics.

    abstract::Data obtained from 23 critically ill patients treated with intravenous ciprofloxacin in two clinical trials were used to validate prospectively a previously developed maximum a posteriori (MAP)-Bayesian estimator and optimal plasma-sampling strategy (OSS). Dosages ranged from 200 mg every 12 hours to 400 mg every 8 ho...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:

    authors: Amsden GW,Ballow CH

    更新日期:1996-09-01 00:00:00

  • Zidovudine pharmacokinetics in five HIV seronegative patients undergoing continuous ambulatory peritoneal dialysis.

    abstract::A few reports in the literature describe zidovudine (AZT) pharmacokinetics in patients undergoing hemodialysis; however, the effect of continuous ambulatory peritoneal dialysis (CAPD) on the drug's disposition has not been studied. The pharmacokinetics of AZT were evaluated in five patients, age 37-62 years, who were ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:

    authors: Kremer D,Munar MY,Kohlhepp SJ,Swan SK,Stinnett EA,Gilbert DN,Young EW,Bennett WM

    更新日期:1992-01-01 00:00:00

  • Evaluation of the ability of seven herbal resources to answer questions about herbal products asked in drug information centers.

    abstract:STUDY OBJECTIVE:To evaluate the ability of seven widely known herbal references and electronic databases to answer questions about herbal products asked at drug information centers. DESIGN:Cross-sectional study. SETTING:Five academic and institutional drug information centers. METHODS:Fifty-seven herbal-related ques...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.22.17.1611.34126

    authors: Walker JB

    更新日期:2002-12-01 00:00:00

  • Limitations of traditional anticoagulants.

    abstract::Warfarin and unfractionated heparin have been in clinical use for more than 50 years. Both are effective anticoagulants, but their use is associated with a number of impediments, including the need for intensive coagulation monitoring, wide variation in dose-response relationships, multiple drug interactions (in the c...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1592/phco.24.10.62s.36120

    authors: Hawkins D

    更新日期:2004-07-01 00:00:00

  • Use of Newer Anticonvulsants for the Treatment of Status Epilepticus.

    abstract::Status epilepticus (SE) has a high mortality rate and is one of the most common neurologic emergencies. Fast progression of this neurologic emergency and lack of response to traditional antiepileptic drugs (AEDs) in most cases has challenged clinicians to use new agents. This article evaluates the efficacy and safety ...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.2229

    authors: Farrokh S,Bon J,Erdman M,Tesoro E

    更新日期:2019-03-01 00:00:00

  • Methods to assess the economic outcomes of clinical pharmacy services.

    abstract::Studies that demonstrate the clinical and economic burden of drug misadventures have been published. The economic burden of drug misadventures likely exceeds $100 billion annually in the United States alone. Clinical pharmacy services (CPS) have been shown to reduce negative clinical outcomes and costs of drug therapy...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.20.16.243s.35018

    authors: Schumock GT

    更新日期:2000-10-01 00:00:00

  • Tenofovir-emtricitabine therapy for the prevention of hepatitis B recurrence in four patients after liver transplantation.

    abstract::In patients infected with chronic hepatitis B virus (HBV) that goes untreated, therapeutic options are limited once the disease decompensates, and orthotopic liver transplantation is often the only treatment available to save the patient's life. After liver transplantation, combined therapy with hepatitis B immune glo...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.1306

    authors: McGonigal KH,Bajjoka IE,Abouljoud MS

    更新日期:2013-09-01 00:00:00

  • Key articles and guidelines in the management of hypertension: 2008 update.

    abstract::Hypertension remains a major risk factor for cardiovascular disease. The optimal choice of pharmacologic and nonpharmacologic treatment regimens is based on a plethora of published literature. This compilation is the initial update to the Key Articles and Guidelines in the Management of Hypertension authored by member...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.28.8.1041

    authors: Gaffney SM,de Denus S,Olson KL,Ripley TL,Robinette B,Summers KM,Spencer AP

    更新日期:2008-08-01 00:00:00

  • Impact of High-Dose Acyclovir Cytomegalovirus Prophylaxis Failure in Abdominal Solid Organ Transplant Recipients.

    abstract:STUDY OBJECTIVE:To evaluate the clinical course and long-term impact of high-dose acyclovir (HD-A, 800 mg 4 times/day) cytomegalovirus (CMV) prophylaxis failure in a CMV-seropositive abdominal solid organ transplant population. DESIGN:Retrospective cohort study. SETTING:Tertiary academic medical center. PATIENTS:A t...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2126

    authors: Siodlak M,Jorgenson MR,Descourouez JL,Leverson GE,Mandelbrot DA,Smith JA,Redfield RR

    更新日期:2018-07-01 00:00:00

  • Tacrolimus Elimination in Four Patients With a CYP3A5*3/*3 CYP3A4*22/*22 Genotype Combination.

    abstract::Cytochrome P450 3A5 (CYP3A5) and cytochrome P450 3A4 (CYP3A4) are the predominate enzymes responsible for tacrolimus metabolism. The presence of CYP3A4 and CYP3A5 genetic variants significantly affects tacrolimus clearance and dose requirements. CYP3A5*3 is a loss-of-function variant resulting in no CYP3A5 enzyme prod...

    journal_title:Pharmacotherapy

    pub_type:

    doi:10.1002/phar.2131

    authors: Scheibner A,Remmel R,Schladt D,Oetting WS,Guan W,Wu B,Dorr C,Israni A,Jacobson PA

    更新日期:2018-07-01 00:00:00

  • Clinical Outcomes with Penicillin Versus Alternative β-Lactams in the Treatment of Penicillin-Susceptible Staphylococcus aureus Bacteremia.

    abstract:OBJECTIVES:To identify the impact of penicillin versus alternative β-lactams on clinical outcomes in patients with penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia. DESIGN:Retrospective cohort study. SETTING:Academic medical center. PATIENTS:Adult patients with PSSA bacteremia treated with a β-lactam a...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1002/phar.2124

    authors: Shah MD,Wardlow LC,Stevenson KB,Coe KE,Reed EE

    更新日期:2018-07-01 00:00:00

  • Superwarfarin and glass ingestion with prolonged coagulopathy requiring high-dose vitamin K1 therapy.

    abstract::A 23-year-old man was brought to the emergency department after eating four boxes of brodifacoum-containing rodenticide over a 4-day interval and pieces from approximately two bottles of glass over the previous 2 weeks. He was asymptomatic but his prothrombin time was markedly elevated with an international normalized...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.23.10.1186.32755

    authors: Tsutaoka BT,Miller M,Fung SM,Patel MM,Olson KR

    更新日期:2003-09-01 00:00:00

  • Reteplase for dysfunctional hemodialysis catheter clearance.

    abstract:STUDY OBJECTIVE:To evaluate the efficacy of reteplase administration in clearing hemodialysis catheters. DESIGN:Open-label, uncontrolled, observational trial. SETTING:University medical center. PATIENTS:Thirty-four patients with end-stage renal disease undergoing long-term hemodialysis. INTERVENTION:Patients had du...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章

    doi:10.1592/phco.23.2.137.32086

    authors: Hilleman DE,Dunlay RW,Packard KA

    更新日期:2003-02-01 00:00:00

  • Aspirin for primary prevention of cardiovascular disease events.

    abstract::Aspirin has been used for the prevention and treatment of cardiovascular disease (CVD) for several decades. The efficacy of aspirin for secondary prevention of cardiovascular disease is well established, but the clinical benefit of aspirin for primary prevention of CVD is less clear. The primary literature suggests th...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/phar.1127

    authors: Nemerovski CW,Salinitri FD,Morbitzer KA,Moser LR

    更新日期:2012-11-01 00:00:00

  • Principles of drug literature evaluation for observational study designs.

    abstract::Clinical pharmacists must often interpret and use data derived from observational studies when making clinical decisions and recommendations, answering drug information questions, and educating patients about drug therapy. This is the third article in a three-part series intended to enhance clinical pharmacists' under...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章

    doi:10.1592/phco.31.2.115

    authors: Shields KM,DiPietro NA,Kier KL

    更新日期:2011-02-01 00:00:00

  • Use of novel antipsychotic drugs.

    abstract::The atypical antipsychotic agents clozapine and risperidone bring new insight into the care and treatment of patients with schizophrenia. Since their introduction, several names (e.g., novel, atypical, serotonergic-dopaminergic antagonist) have been used to describe the nature of these compounds. The agents are unique...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Raleigh F

    更新日期:1996-11-01 00:00:00

  • Tissue plasminogen activator: an evaluation of clinical efficacy in acute myocardial infarction.

    abstract::Recombinant tissue plasminogen activator (t-PA) is a synthetic fibrinolytic protein which activates plasminogen or converts plasminogen to plasmin specifically in the presence of fibrin. With its "clot-selectivity", t-PA is capable of lysing clots without having a significant effect on circulating plasminogen. In cont...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:10.1002/j.1875-9114.1987.tb04035.x

    authors: Rogers SD,Riemersma LB,Clements SD

    更新日期:1987-01-01 00:00:00

  • Comparison of prescription drug costs in the United States and the United Kingdom, part 2: proton pump inhibitors.

    abstract:STUDY OBJECTIVE:To compare the annual cost of proton pump inhibitors (PPIs) in the United States and in the United Kingdom. DESIGN:Matched-cohort cost analysis. DATA SOURCES:U.K. General Practice Research Database (GPRD) and MarketScan Commercial Claims and Encounter Database, a large, U.S. self-insured medical claim...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,随机对照试验

    doi:10.1002/j.1875-9114.2012.01111.x

    authors: Jick H,Wilson A,Wiggins P,Chamberlain DP

    更新日期:2012-06-01 00:00:00

  • Effects of acetaminophen, naproxen, and acetylsalicylic acid on tapentadol pharmacokinetics: results of two randomized, open-label, crossover, drug-drug interaction studies.

    abstract:STUDY OBJECTIVE:To evaluate the effects of acetaminophen, naproxen, and acetylsalicylic acid on the pharmacokinetics of the centrally acting analgesic tapentadol in healthy subjects. DESIGN:Two randomized, open-label, crossover, drug-drug interaction studies. SETTING:Clinical research facilities in the United States ...

    journal_title:Pharmacotherapy

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1592/phco.30.1.25

    authors: Smit JW,Oh C,Rengelshausen J,Terlinden R,Ravenstijn PG,Wang SS,Upmalis D,Mangold B

    更新日期:2010-01-01 00:00:00

  • Monoclonal antibodies in the treatment of steroid-resistant acute graft-versus-host disease.

    abstract::Acute graft-versus-host disease (GVHD) remains the major obstacle for successful allogeneic bone marrow transplantation (BMT). The frequency of grade II or higher acute GVHD ranges from 30-50% in human leukocyte antigen (HLA)-matched sibling transplants and 50-80% in HLA-matched unrelated transplants. The mortality an...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Tse JC,Moore TB

    更新日期:1998-09-01 00:00:00

  • The use of aztreonam in pediatric patients: a review.

    abstract::Aztreonam is the first monobactam available for use in this country. A parenteral antibiotic, its antibacterial spectrum is limited to gram-negative aerobic pathogens. The drug's pharmacologic, pharmacokinetic, and toxicologic properties are reviewed. Based on early experience in pediatric patients, certain recommenda...

    journal_title:Pharmacotherapy

    pub_type: 杂志文章,评审

    doi:

    authors: Bosso JA,Black PG

    更新日期:1991-01-01 00:00:00